Tuberculosis: Challenges to Improve the Treatment

ISSN: 2212-3938 (Online)
ISSN: 1574-8847 (Print)

Volume 12, 4 Issues, 2017

Download PDF Flyer

Current Clinical Pharmacology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Arduino A. Mangoni
Flinders University and Flinders Medical Centre
Adelaide, SA

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Tuberculosis: Challenges to Improve the Treatment

Current Clinical Pharmacology, 10(3): 242-251.

Author(s): Mariana Moreira Lima, Ariane Trindade, Flávia Carnavalli, Aylime Castanho Bolognesi Melchior, Chung Man Chin and Jean Leandro dos Santos.

Affiliation: State University of São Paulo “Júlio de Mesquita Filho” –UNESP, School of Pharmaceutical Science, Drugs and Medicines Departament, Center of Pharmaceutical Care (NAF), Rodovia Araraquara Jaú Km, 01, 14801-902 Araraquara, SP, Brazil.


Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.


Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 3
First Page: 242
Last Page: 251
Page Count: 10
DOI: 10.2174/1574884708666131229124215
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science